Bill Text: NY S09100 | 2017-2018 | General Assembly | Introduced
Bill Title: Enacts the drug take back act requiring certain manufacturers to operate a drug take back program to accept and dispose of covered drugs; provides that for any city with a population of one hundred twenty-five thousand or more as of the last decennial census, the commissioner of health shall establish by regulation a distribution plan that ensures that on-site collection receptacle or dropbox placement shall be reasonably accessible to all residents.
Spectrum: Slight Partisan Bill (Democrat 12-7)
Status: (Passed) 2018-07-10 - SIGNED CHAP.120 [S09100 Detail]
Download: New_York-2017-S09100-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 9100 IN SENATE June 16, 2018 ___________ Introduced by Sens. HANNON, O'MARA -- read twice and ordered printed, and when printed to be committed to the Committee on Rules AN ACT to amend the public health law, in relation to enacting the drug take back act The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. This act shall be known and may be cited as the "drug take 2 back act." 3 § 2. The public health law is amended by adding a new article 2-B to 4 read as follows: 5 ARTICLE 2-B 6 DRUG TAKE BACK 7 Section 290. Definitions. 8 291. Drug take back. 9 292. Collection. 10 293. Violations. 11 294. Jurisdiction. 12 § 290. Definitions. As used in this article, unless the context clear- 13 ly requires otherwise: 14 1. "Authorized collector" means: (a) a person, company, corporation or 15 other entity that is registered with the United States Drug Enforcement 16 Administration to collect controlled substances for the purposes of safe 17 disposal and destruction; (b) a law enforcement agency; or (c) a person, 18 company, corporation or other entity authorized by the department to 19 provide alternative collection methods for covered drugs that are not 20 controlled substances. 21 2. "Covered drug" means any substance recognized as a drug under 21 22 USC § 321(g)(1), as amended, and any regulations promulgated thereunder 23 that is sold, offered for sale or dispensed in the state, whether 24 directly or through a wholesaler, in any form including prescription and 25 nonprescription drugs, drugs in medical devices and combination 26 products, brand and generic drugs and drugs for veterinary use; provided 27 however, covered drug shall not include: (a) vitamins or supplements; 28 (b) herbal-based remedies and homeopathic drugs, products or remedies; EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD14168-16-8S. 9100 2 1 (c) cosmetics, soap (with or without germicidal agents), laundry deter- 2 gent, bleach, household cleaning products, shampoos, sunscreens, tooth- 3 paste, lip balm, antiperspirants or other personal care products that 4 are regulated as both cosmetics and nonprescription drugs under the 5 Federal Food, Drug, and Cosmetic Act; (d) pet pesticide products 6 contained in pet collars, powders, shampoos, topical applications, or 7 other forms; (e) drugs that are biological products as defined in subdi- 8 vision twenty-seven of section sixty-eight hundred two of the education 9 law if the manufacturer already provides a take back program; (f) drugs 10 for which a manufacturer provides a take back program as part of a 11 Federal Food and Drug Administration managed risk evaluation and miti- 12 gation strategy; (g) emptied injector products or emptied medical 13 devices and their component parts or accessories; and (h) drugs that are 14 used solely in a clinical setting. 15 3. "Manufacturer" means a person, company, corporation or other entity 16 engaged in the manufacture of covered drugs sold in the state. Manufac- 17 turer does not include a repackager or wholesaler. 18 4. "Pharmacies" means all pharmacies registered under section sixty- 19 eight hundred eight of the education law that are part of a group of ten 20 or more establishments that conduct business under the same name, or 21 operate under a common ownership or management, or pursuant to a fran- 22 chise agreement with the same franchisor, and all nonresident pharmacies 23 registered pursuant to section sixty-eight hundred eight-b of the educa- 24 tion law that provide covered drugs to state residents by mail. 25 5. "Drug take back organization" means an organization designated by a 26 manufacturer or a group of manufacturers to act as an agent on behalf of 27 the manufacturer or group of manufacturers to operate and implement a 28 drug take back program as authorized by this article. 29 6. "Wholesaler" means any person, company, corporation or other entity 30 that sells or distributes drugs and covered drugs for resale to an enti- 31 ty in the state other than a consumer. 32 7. "Repackager" means an entity that owns or operates an establishment 33 that repacks and relabels a product or package containing a covered drug 34 for further sale or for distribution without further transaction. 35 § 291. Drug take back. 1. Any manufacturer of a covered drug shall: 36 (a) operate a drug take back program approved by the department indi- 37 vidually or jointly with other manufacturers; 38 (b) enter into an agreement with a drug take back organization which 39 shall operate a drug take back program approved by the department; or 40 (c) enter into an agreement with the department to operate a drug take 41 back program on its behalf. 42 2. Any manufacturer of a covered drug, individually or jointly, or a 43 drug take back organization contracted by a manufacturer of a covered 44 drug shall within one hundred eighty days from the effective date of 45 this section submit to the department, in a manner and form determined 46 by the department, a proposed drug take back program that meets, at a 47 minimum, the following requirements: 48 (a) Certifies the drug take back program will accept all covered drugs 49 regardless of who produced them; 50 (b) Provides contact information for the person submitting the planned 51 drug take back program with whom the department shall direct all 52 inquiries; 53 (c) Details a collection system to provide convenient, ongoing 54 collection services to all persons seeking to dispose of covered drugs 55 pursuant to section two hundred ninety-two of this article that isS. 9100 3 1 geographically distributed in a way to ensure access in rural and under- 2 served areas; 3 (d) Describes other collection methods by which covered drugs will be 4 collected by authorized collectors; 5 (e) Explains how covered drugs will be safely and securely tracked and 6 handled from collection through final disposal and destruction, policies 7 to ensure security and compliance with all applicable laws and regu- 8 lations including disposal and destruction at a permitted waste disposal 9 facility meeting federal requirements; 10 (f) Describes the public education and outreach activities that will 11 be undertaken which shall include advertising of collection locations on 12 a website and through use of signage and other written materials, and 13 how effectiveness will be evaluated; 14 (g) Details how the costs of pharmacy collection and other authorized 15 collectors will be reimbursed which shall include costs retroactive to 16 the effective date of this article, and where more than one manufacturer 17 will be involved in the planned drug take back program, a plan for the 18 fair and reasonable manner of allocated costs among the participants in 19 such program such that the costs paid by each manufacturer is reasonably 20 related to the volume or value of covered drugs sold in the state; and 21 (h) Provides any further information deemed appropriate by the depart- 22 ment. 23 3. Within thirty days of the effective date of this section, each 24 wholesaler that sells covered drugs in or into the state shall provide 25 the department with a list of manufacturers that produce covered drugs. 26 The department may request updated lists at its discretion. 27 4. A manufacturer, individually or jointly, must pay all administra- 28 tive and operational fees associated with the drug take back program, 29 including the cost of collecting, transporting and disposing of covered 30 drugs from pharmacies and other authorized collectors and the recycling 31 or disposal, or both, of packing collected with the covered drug. 32 Manufacturers shall also pay costs incurred by the state in the adminis- 33 tration and enforcement of the drug take back program. Exclusive of 34 fines and penalties, the state shall only recover its actual cost of 35 administration and enforcement. In instances where manufacturers jointly 36 conduct a drug take back program, the costs of administration and 37 enforcement shall be fairly and reasonably allocated such that the 38 portion of costs is reasonably related to the volume or value of covered 39 drugs the manufacturers sell in the state. No manufacturer may charge a 40 point-of-sale or other fee to consumers, or a fee that could be passed 41 on to consumers, to recoup the cost of their drug take back program. 42 5. Within sixty days of receipt of a proposed drug take back program, 43 the department, in consultation with the department of environmental 44 conservation, shall determine whether such proposed drug take back 45 program complies with the requirements of this article and notify the 46 applicant. The department may conduct a noticed public hearing prior to 47 approval. If the drug take back program is approved, the department 48 shall notify the applicant in writing. If the drug take back program is 49 not approved, the department shall notify the applicant in writing and 50 the applicant shall submit a revised drug take back program proposal 51 within thirty days. If the department rejects the subsequent proposal, 52 the manufacturer or manufacturers at issue shall be out of compliance 53 with this article and subject to the enforcement provisions pursuant to 54 section two hundred ninety-four of this article. The department shall 55 provide, and update annually, on its website a list of all manufacturers 56 participating in a drug take back program approved by the department.S. 9100 4 1 6. At least every three years, a manufacturer, jointly or individual- 2 ly, or a drug take back organization shall update its drug take back 3 program and submit an updated proposal to the department. A manufacturer 4 who begins to offer a covered drug in the state after the effective date 5 of this article, shall provide evidence of joining an existing approved 6 drug take back program or submit a proposal for a drug take back program 7 within ninety days following the initial offer for sale of a covered 8 drug. Any proposed change to a drug take back program shall be submitted 9 in writing and approved by the department prior to any change. 10 7. Each approved drug take back program shall report to the department 11 at a date and manner set by the department. The department shall submit 12 an annual report to the governor, speaker of the assembly and temporary 13 president of the senate by January first detailing all program activ- 14 ities, the weight collected by each program, a description of collection 15 activities, the name and location of all collection sites, public educa- 16 tion and outreach activities, an evaluation of the efficacy of the 17 program and each collection method, and any manufacturer out of compli- 18 ance or subject to penalties pursuant to section two hundred ninety-four 19 of this article. 20 § 292. Collection. 1. All pharmacies shall provide for the safe 21 collection of drugs, which shall include: 22 (a) Offering drug collection by one or more of the following methods: 23 (i) On-site collection, dropbox, or receptacle meeting federal stand- 24 ards; 25 (ii) Mail-back collection by prepaid envelopes as authorized by feder- 26 al law and regulation; or 27 (iii) Other federal drug enforcement agency approved methods of 28 collection. 29 (b) Signage prominently displayed advertising such drug collection to 30 consumers. 31 2. All drug take back program operators shall notify other potential 32 authorized collectors of the opportunity to serve as an authorized 33 collector for the drug take back program. Participation of authorized 34 collectors besides pharmacies shall be voluntary. 35 3. All costs of pharmacies and other authorized collectors shall be 36 paid or reimbursed by the manufacturer, jointly or individually, as part 37 of the drug take back programs required by this article. 38 4. For any city with a population of one hundred twenty-five thousand 39 or more as of the last decennial census, the commissioner shall estab- 40 lish by regulation a distribution plan that ensures that on-site 41 collection receptacle or dropbox placement shall be reasonably accessi- 42 ble to all residents and that provides for program cost efficiency. 43 5. Pharmacies providing for mail-back collection as part of the drug 44 take back program shall provide a voucher for a prepaid envelope upon 45 dispensing a covered drug. Such voucher shall include information on 46 drug take back and safe drug disposal methods. 47 § 293. Violations. Violation of this article shall be subject to fines 48 pursuant to section twelve of this chapter. Each day in which the 49 violation continues shall constitute a separate violation. 50 § 294. Jurisdiction. Jurisdiction of all matters pertaining to drug 51 disposal by this article is vested exclusively in the state. Any 52 provision of any local law or ordinance, or any rule or regulation 53 promulgated prior to, or upon the effective date of this section, shall 54 be preempted. 55 § 3. Section 3343-b of the public health law, as amended by chapter 56 379 of the laws of 2015, is amended to read as follows:S. 9100 5 1 § 3343-b. Safe disposal of unused controlled substances. 1. The 2 department shall oversee a program for the safe disposal of unused 3 controlled substances by consumers in accordance with federal law and 4 article two-B of this chapter. Individual members of the public shall 5 be authorized to voluntarily surrender controlled substances listed on 6 schedule II, III, IV or V of section thirty-three hundred six of this 7 article in a secure manner, without identifying themselves. Safe 8 disposal methods shall be publicized consistent with the prescription 9 pain medication awareness program established pursuant to section thir- 10 ty-three hundred nine-a of this article and article two-B of this chap- 11 ter. 12 2. The surrender of a controlled substance pursuant to this section 13 and article two-B of this chapter shall not constitute the possession, 14 transfer or sale of such controlled substance for purposes of this arti- 15 cle or the penal law. 16 3. [Disposal] Except as provided in article two-B of this chapter, 17 disposal sites shall be operated by law enforcement agencies, pharmacies 18 and other Federal Drug Enforcement Administration authorized collectors 19 on a voluntary basis, provided, however, that such disposal sites shall 20 not be precluded from operating as part of a drug take back program 21 established pursuant to article two-B of this chapter. Nothing in this 22 section shall require any political subdivision of the state to partic- 23 ipate in the program established in this section. 24 § 4. The department of health may adopt regulations as necessary to 25 implement and enforce the provisions of this title. 26 § 5. This act shall take effect on the one hundred eightieth day after 27 it shall have become a law. Effective immediately, the addition, amend- 28 ment and/or repeal of any rule or regulation necessary for the implemen- 29 tation of this act on its effective date are authorized to be made and 30 completed on or before such effective date.
